Grant: Discovery Grants Program - Individual
University of Alberta
$301,000.00
Ultra-sensitive assays for DNA damage, mutation, and DNA-protein interaction
FY 2022-23
Summary
This research program aims to advance analytical technology for studying DNA damage and mutation. The proposed research focuses on: (1) developing analytical techniques for measuring DNA damage on specific gene locations; (2) imaging specific DNA mutations in live cells; and (3) applying the new techniques to real-time monitoring of molecular processes in the cells. Damage at particular sites in human DNA is known to lead to various adverse outcomes. The critical role of DNA damage makes it essential to develop highly sensitive and specific assays for DNA damage. The first objective of this research is to develop a new analytical technology that will locate the specific damage on the target gene and quantify the abundance of the damage at the same time. This technology uses two rationally designed molecular probes, one binding to the DNA damage and the other binding to the specific gene. Binding of both probes to the same DNA molecule produces a new detectable DNA assembly. The ultra-sensitive technique will be applied to the detection of specific DNA damage caused by environmental and clinical agents, such as ultraviolet light, cancer treatment drugs, and environmental contaminants.The second objective is to establish a new method for imaging DNA mutations in live cells. The new method takes advantage of a powerful genome engineering technology, called CRISPR. This technology uses a set of molecules to locate the target site in the genome, make cuts to the DNA at the target site, and then edit and repair the cuts, accomplishing genome editing at the target site. In this research, the unique ability of CRISPR to locate and bind to specific sites of the genome will be used to deliver a specially designed fluorescence probe to the target site. Binding of this probe to the specific mutations in the DNA will turn on the fluorescence. Monitoring of the fluorescence generated in the cells will enable real-time imaging of the mutations. The third objective is to extend the applications of the new techniques to studying molecular interactions and visualizing chemical processes in the cells. The concept and strategy of the proposed analytical technologies and methods are also applicable to many other compounds of biochemical, environmental, and clinical importance.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2018-06913
Name nom
Le, X Chris
Department département
Laboratory Medicine and Pathology - Laboratory Medicine and Pathology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
301000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Ultra-sensitive assays for DNA damage, mutation, and DNA-protein interaction
Application summary
This research program aims to advance analytical technology for studying DNA damage and mutation. The proposed research focuses on: (1) developing analytical techniques for measuring DNA damage on specific gene locations; (2) imaging specific DNA mutations in live cells; and (3) applying the new techniques to real-time monitoring of molecular processes in the cells. Damage at particular sites in human DNA is known to lead to various adverse outcomes. The critical role of DNA damage makes it essential to develop highly sensitive and specific assays for DNA damage. The first objective of this research is to develop a new analytical technology that will locate the specific damage on the target gene and quantify the abundance of the damage at the same time. This technology uses two rationally designed molecular probes, one binding to the DNA damage and the other binding to the specific gene. Binding of both probes to the same DNA molecule produces a new detectable DNA assembly. The ultra-sensitive technique will be applied to the detection of specific DNA damage caused by environmental and clinical agents, such as ultraviolet light, cancer treatment drugs, and environmental contaminants.The second objective is to establish a new method for imaging DNA mutations in live cells. The new method takes advantage of a powerful genome engineering technology, called CRISPR. This technology uses a set of molecules to locate the target site in the genome, make cuts to the DNA at the target site, and then edit and repair the cuts, accomplishing genome editing at the target site. In this research, the unique ability of CRISPR to locate and bind to specific sites of the genome will be used to deliver a specially designed fluorescence probe to the target site. Binding of this probe to the specific mutations in the DNA will turn on the fluorescence. Monitoring of the fluorescence generated in the cells will enable real-time imaging of the mutations. The third objective is to extend the applications of the new techniques to studying molecular interactions and visualizing chemical processes in the cells. The concept and strategy of the proposed analytical technologies and methods are also applicable to many other compounds of biochemical, environmental, and clinical importance.